Results 131 to 140 of about 8,816 (206)

COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer. [PDF]

Oncologist
Mehlman C, Swalduz A, Monnet I, Morin C, Wislez M, Guisier F, Curcio H, Du Rusquec P, Cortot AB, Gounant V, Abbar B, Duchemann B, Giroux-Leprieur E, Pierret T, Quilot FM, Cadranel J, Fallet V.   +16 more
europepmc   +1 more source

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer. [PDF]

Ther Adv Med Oncol
Roboubi A, Wasielewski E, Bordier S, Turlotte A, Pavaut G, Scherpereel A, Cortot A, Gauvain C.   +7 more
europepmc   +1 more source

Signes annonciateurs du décès. [PDF]

CMAJ
Marx H.
europepmc   +1 more source

Streamlining lung cancer management in Nova Scotia amid COVID-19: pooled triaging for expedited curative-intent oncologic surgery. [PDF]

Can J Surg
Patel P, Brownstone R, Cruickshank B, Garagan C, Manos D, French D, Wallace A, Plourde M.   +7 more
europepmc   +1 more source

Rhombencéphalite chez une femme de 86 ans atteinte de leucémie lymphoïde chronique. [PDF]

CMAJ
Tilley B, Kim VS, Lass E, Masellis M, Silverstein WK.   +4 more
europepmc   +1 more source

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact. [PDF]

Ther Adv Med Oncol
Lejeune M, Wasielewski E, Leroy V, Bordier S, Scherpereel A, Cortot A, Gauvain C.   +6 more
europepmc   +1 more source

Trends and variations in Canadian thoracic surgical volume and perioperative practice during the COVID-19 pandemic. [PDF]

Can J Surg
Jones D, Simone A, Hyun C, Anstee C, Gingrich M, Villeneuve J, French D, Johnston B, Gowing S, Spicer J, Ferri L, Seely AJE.   +11 more
europepmc   +1 more source

Programme pilote de rééducation sensitive des neuropathies périphériques induites par la chimiothérapie (NPIC) auprès d’une clientèle oncologique. [PDF]

Can Oncol Nurs J
Hébert J, Bergeron AS, Claveau C.
europepmc   +1 more source